Six new companies join CO-AX Accelerator at Sahlgrenska Science Park
The new cohort brings together startups working across diagnostics, therapeutics, AI and digital health, strengthening the life science and healthtech ecosystem at Sahlgrenska Science Park.
Strengthening the ecosystem through new companies
The new cohort reflects the breadth of innovation emerging within life science and healthtech, spanning advanced diagnostics and therapeutics, AI-supported clinical decision-making and digital platforms for healthcare research.
The selected companies are developing solutions addressing challenges across prevention, diagnosis, treatment and clinical workflows. Through CO-AX Accelerator, they gain access to tailored business support, industry expertise and a strong cross-sector network.
The companies joining the CO-AX Accelerator
Bioelectrix - co incubated with Chalmers Ventures and part of Chalmers Ventures portfolio.
Develops bioelectronic wound care solutions using biocompatible electrostimulation and real-time monitoring to accelerate the healing of hard-to-heal wounds.
Arvakor
Focused on innovative therapeutic approaches addressing unmet medical needs, with the ambition to improve patient outcomes through cutting-edge science.
Nanocept
Combines nanotechnology and diagnostics to enable earlier and more precise disease detection, supporting improved clinical decision-making.
Modernizes clinical trial recruitment by connecting patients and researchers through a digital platform, with a strong focus on increasing the participation of women to support more inclusive and representative research.
Develops CLARA, an AI-driven Clinical Language and Reasoning Agent that supports clinicians by summarizing and interpreting medical information to improve clinical workflows.
Develops a non-invasive wearable soundwave therapy delivering CSWT for patients with refractory angina beyond the hospital setting.
Supporting innovation with real-world impact
CO-AX supports startups with ambitions to scale innovations that address real healthcare needs. The accelerator offers support in areas such as business development, product validation, regulatory strategy, access to capital and connections to healthcare and industry partners. Stay tuned for upcoming Spring applications 2025 at CO-AX accelerator!
About CO-AX
The CO-AX Accelerator, based at Sahlgrenska Science Park, supports entrepreneurs developing technology-driven solutions to global health challenges. By combining deep sector expertise with a strong collaborative ecosystem, CO-AX helps startups accelerate growth and move innovations closer to real-world implementation in healthcare.